Sarda Proteins fixes July 23 cut-off date for EGM e-voting
Sarda Proteins Limited has fixed July 23, 2026, as the cut-off date for its EGM on July 30, 2026, to approve increasing authorised share capital to ₹100 crore and renaming the company to Sarda Enterprises Limited. The meeting will also consider appointing Shirish Dhirajlal Savaliya as Managing Director and Mr. Yagnik Satasiya as Non-Executive Chairperson. Remote e-voting is available from July 27 to July 29, 2026.
*this image is generated using AI for illustrative purposes only.
Sarda Proteins Limited has fixed July 23, 2026, as the cut-off date to determine shareholder eligibility for voting at its Extraordinary General Meeting (EGM) scheduled for July 30, 2026. The meeting, conducted via audio-visual means, will seek shareholder approval to increase the authorised share capital from ₹13 crore to ₹100 crore and change the company's name to Sarda Enterprises Limited to reflect its diversified business strategy. These moves are aimed at providing financial flexibility for growth and aligning the corporate identity with expanded operations.
The Board of Directors proposes to alter Clause V of the Memorandum of Association to facilitate the capital increase. This adjustment is intended to meet long-term capital requirements for business expansion and potential future fund-raising activities. The company also seeks to amend the main object clause to include activities related to agriculture, horticulture, and food processing, alongside its existing operations.
Shareholders will vote on the appointment and regularization of several key personnel. The Board recommends appointing Shirish Dhirajlal Savaliya as Managing Director for a period of five years effective July 4, 2026, with a monthly remuneration of ₹2,10,000. Additionally, Mr. Yagnik Satasiya is proposed to be designated as the Non-Executive Chairperson for a five-year term. The EGM will also confirm the appointments of Mr. Gunvantray Jayantilal Zaladi and Mr. Shivam Gunvantray Zaladi as Non-Executive, Non-Independent Directors.
The proposal to change the name to Sarda Enterprises Limited follows the Board's decision to diversify into various sectors. The company stated that the new name more appropriately reflects its current objectives and future growth plans. The change will not affect the legal status or continuity of the company or the rights of its members and creditors.
Remote e-voting for the meeting will commence on July 27, 2026, at 9:00 A.M. (IST) and conclude on July 29, 2026, at 5:00 P.M. (IST). Shareholders whose names appear in the Register of Members or the Register of Beneficial Owners as on the cut-off date of July 23, 2026, will be entitled to vote.
| Agenda Item | Description |
|---|---|
| Increase in Authorised Capital | From ₹13,00,00,000 to ₹1,00,00,00,000 |
| Change of Name | Sarda Proteins Limited to Sarda Enterprises Limited |
| Managing Director Appointment | Shirish Dhirajlal Savaliya (5 years) |
| Chairperson Appointment | Mr. Yagnik Satasiya (Non-Executive, 5 years) |
What specific acquisitions or capital expenditures does Sarda Proteins plan to finance with the proposed ₹87 crore increase in authorised share capital?
How will the diversification into agriculture, horticulture, and food processing impact the company's core protein business margins in the short term?
What is the strategic rationale behind appointing a new Managing Director and Chairperson concurrently with the major corporate restructuring?
Access Market Heat-map & Insights 
Create, Save & Share your Screener 
Use 200+ Screening Filters 
